Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Fiscal 2009 Budget: Will Congress Throw Money After Rhetorical Salvos?

Executive Summary

The Bush Administration's effort to portray its proposed fiscal year 2009 FDA budget of $2.4 billion as a step toward revitalizing the agency is falling on deaf ears among Democrats

You may also be interested in...



Generic Drug Fees In, DTC Fees Dropped, From Obama Budget Proposal

Some of FDA's funding increase promised in President Obama's budget comes from user fees which would have to be established legislatively - meaning that the administration will have to negotiate with industry and congressional authorizing committees, not just House and Senate appropriators, in order to see its vision enacted

Generic Drug Fees In, DTC Fees Dropped, From Obama Budget Proposal

Some of FDA's funding increase promised in President Obama's budget comes from user fees which would have to be established legislatively - meaning that the administration will have to negotiate with industry and congressional authorizing committees, not just House and Senate appropriators, in order to see its vision enacted

FDA Product Safety Initiative Gets $166 Million In FY ’10 Budget Proposal

A $166 million initiative aimed at ensuring supply chain safety and security for medical products is part of the $3.2 billion fiscal year 2010 FDA budget proposed by the Obama administration

Related Content

UsernamePublicRestriction

Register

LL1134420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel